| Formulary Chapter 1: Gastro-intestinal system - Full Section
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
01.01 |
Dyspepsia and gastro-oesophageal reflux disease
(0,1)
|
|
|
Dyspepsia (0,0)
|
|
|
Gastro-oesophageal reflux disease (0,0)
|
|
01.01.01 |
Antacids and simeticone (0,0)
|
|
|
Aluminium and magnesium containing antacids
(4,0)
|
|
|
Antacid preparations containing simeticone (0,0)
|
|
|
Simeticine alone
(0,2)
|
|
|
Antacid preparations containing dimeticone or local anaesthetics (0,0)
|
|
01.01.02 |
Compound alginates and proprietary indigestion preparations (0,0)
|
|
|
Compound alginate preparations
(3,1)
|
|
01.02 |
Antispasmodics and other drugs altering gut motility (0,0)
|
|
|
Antimuscarinics
(2,1)
|
|
|
Other antispasmodics
(6,0)
|
|
|
Motility stimulants (0,0)
|
|
01.03 |
Antisecretory drugs and mucosal protectants (0,0)
|
|
|
Helicobacter pylori infection (0,0)
|
|
|
NSAID-associated ulcers (0,0)
|
|
01.03.01 |
H2-receptor antagonists
(2,0)
|
|
01.03.02 |
Selective antimuscarinics (0,0)
|
|
01.03.03 |
Chelates and complexes
(1,0)
|
|
01.03.04 |
Prostaglandin analogues
(1,0)
|
|
01.03.05 |
Proton pump inhibitors (PPIs)
(7,0)
|
|
01.03.06 |
Other ulcer-healing drugs (0,0)
|
|
01.04 |
Acute diarrhoea (0,0)
|
|
01.04.01 |
Adsorbents and bulk-forming drugs (0,0)
|
|
01.04.02 |
Antimotility drugs
(3,0)
|
|
01.04.03 |
Enkephalinase Inhibitors (0,0)
|
|
01.05 |
Chronic bowel disorders (0,0)
|
|
|
Irritable bowel syndrome (0,0)
|
|
|
Malabsorption syndromes (0,0)
|
|
|
Inflammatory bowel disease
(1,0)
|
|
|
Antibiotic-associated colitis (0,0)
|
|
|
Diverticular disease (0,0)
|
|
01.05.01 |
Aminosalicylates
(8,0)
|
|
01.05.02 |
Corticosteroids
(9,0)
|
|
|
Oral (0,0)
|
|
01.05.03 |
Drugs affecting the immune response
(3,0)
|
|
|
Cytokine inhibitors
(2,0)
|
|
|
Vedolizumab
(1,0)
|
|
01.05.04 |
Food allergy (0,0)
|
|
01.06 |
Laxatives
(1,0)
|
|
01.06.01 |
Bulk-forming laxatives
(3,0)
|
|
01.06.02 |
Stimulant laxatives
(7,0)
|
|
|
Other Stimulant laxatives (0,0)
|
|
01.06.03 |
Faecal softeners (0,0)
|
|
01.06.04 |
Osmotic laxatives
(4,0)
|
|
01.06.05 |
Bowel cleansing preparations
(1,0)
|
|
01.06.06 |
Peripheral opiod-receptor antagonist
(2,0)
|
|
01.06.07 |
5HT4 receptor agonists and guanylate cyclase-C receptor agonists
(0,2)
|
|
01.07 |
Local preparations for anal and rectal disorders (0,0)
|
|
01.07.01 |
Soothing haemorrhoidal preparations (0,0)
|
|
01.07.02 |
Compound haemorrhoidal preparations with corticosteroids
(4,0)
|
|
01.07.03 |
Rectal sclerosants (0,0)
|
|
01.07.04 |
Management of anal fissures
(2,0)
|
|
01.09 |
Drugs affecting intestinal secretions (0,0)
|
|
01.09.01 |
Drugs affecting biliary composition and flow
(2,0)
|
|
|
Other prepatations for biliary disorders (0,0)
|
|
01.09.02 |
Bile acid sequestrants
(1,0)
|
|
01.09.03 |
Aprotinin (0,0)
|
|
01.09.04 |
Pancreatin
(1,0)
|
